We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > lopinavir

News List

Lopinavir-ritonavir not an effective treatment for COVID-19, study shows europeanpharmaceuticalreview
October 16, 2020
A clinical trial in the UK has shown that lopinavir-ritonavir is not an effective treatment for patients admitted to hospital with COVID-19.
Mylan Waives Marketing Exclusivity in US for Lopinavir/Ritonavir for COVID-19 Needs americanpharmaceuticalreview
March 31, 2020
Mylan announced, in its ongoing effort to support patients and public health needs in the current circumstances surrounding the COVID-19 pandemic.
AbbVie’s HIV drug combo shows no benefit in Covid-19 trial pharmaceutical-technology
March 20, 2020
A clinical trial in Covid-19 patients in China has yielded no therapeutic benefits with AbbVie’s HIV drug combination of lopinavir and ritonavir, marketed as Kaletra.